# Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures

> **NCT05518279** · PHASE3 · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Hip Fractures
- Blood Loss

## Interventions

- **DRUG:** Tranexamic Acid Pill
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT05518279
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09
- **Primary completion:** 2021-08
- **Final completion:** 2021-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not work out internal logistics
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05518279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05518279, "Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT05518279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*